2Couser WG, Nangaku M. Cellular and molecular biology of membranous nephropathy [ J ]. J Am Soc Nephrol,2007,18 ( 1 ) :29-36.
3Yao X, Chen H,Wang Q,et al. Cyclosporin A treatment for idiopathic membranous nephropathy [ J ]. Chin Med J (Engl) , 2001,114 (12) :1305-1308.
4Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial [ J]. Kidney Int,2001,59(4) : 1484-1490.
5Miller G,Zimmerman R,Radhakrishnan J,et al. Use of mycophenolate mofetil in resistant membranous nephropathy[ J ]. Am J Kidney Dis, 2000,36 ( 2 ) : 250 -256.
6Branten AJ, Reichert LJ, Koene RA, et al. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency[ J]. Q j Med, 1998,91 (5) :359- 366.
7Ponticelli C,Altieri P, Scolari F,et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy[ J]. J Am Soc Nephrol,1998,9(3) :444-450.
8Perna A, Schieppati A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review [ J]. Am J Kidney Dis,2004,4(43 ) :385-401.
9Diplinger H, Lackner C, Kronen berg F, et al. Elerated Plasma Concentrations of Lipoprotein(a) in Patients with End-stage Renal Disease Are Not Related to the Size Polymorphism of Apolipoprotein(a ). J Clin Invest, 1993,91 (2):397.
10Coritsidis G, Rifici V, Gupta S, et al. Perferential binding of oxidized LDL to rat glomeruli invivo and cultured mesangial cells in vitro. Kidney Int, 1991,39: 358.
